3 Reasons to Buy Moderna Stock

The past four years have been a roller-coaster ride for Moderna (MRNA 3.06%). The mRNA-focused vaccine maker rose to prominence following a successful attempt at developing a coronavirus vaccine.However, the stock fell out of favor once sales of the company's only product on the market started moving in the wrong direction. Moderna's shares are down by 30% in the past year, but their total return over the past four years is 230%, and there remain good reasons to invest in the company. 1. Gaining market shar ...